Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4071935

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
S=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3ccccc3Br)c2c1

Basic Information

ChEMBL ID CHEMBL4071935
Phase Preclinical
Structure Type MOL
InChI Key GBYYCQCRVAFUJL-UHFFFAOYSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names

Molecular Properties

464.4
MW (Da)
5.62
ALogP
4
HBA
3
HBD
61.9
PSA (Ų)
0.33
QED
1
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C22H18BrN5S
MW 464.39
Aromatic Rings 4
Heavy Atoms 29
NP-Likeness -1.84

Activity Summary

IC50 1 meas. best 5.19

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.19 5.19 6500.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 6500.0 nM 5.19 Inhibition of TNFalpha-stimulated NF-kappaB (unknown origin) expressed in human ... 28291344

Literature References

PubMed DOI Target Context # Activities
28291344 10.1021/acs.jmedchem.6b01774 Epidermal growth factor receptor 2
28291344 10.1021/acs.jmedchem.6b01774 Unchecked 2
28291344 10.1021/acs.jmedchem.6b01774 MDA-MB-231 1

Data from ChEMBL 36 via Core Engine